362 related articles for article (PubMed ID: 26575871)
1. [Value of amino-terminal pro-brain natriuretic peptide as a predictive marker of symptomatic patent ductus arteriosus in preterm infants].
Lu KS; Guo XL; Lv JF; Huang SL; Yang CH; Zou ZH; Chen ZJ; Lai CH; Yang BY
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1160-4. PubMed ID: 26575871
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
3. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
[TBL] [Abstract][Full Text] [Related]
4. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
Nuntnarumit P; Khositseth A; Thanomsingh P
J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
[TBL] [Abstract][Full Text] [Related]
5. Exploring the NT-proBNP expression in Premature Infants with Patent Ductus Arteriosus (PDA) by Echocardiography.
Shi Y; Ji J; Wang C
Pak J Med Sci; 2021; 37(6):1615-1619. PubMed ID: 34712293
[TBL] [Abstract][Full Text] [Related]
6. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
7. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
Nuntnarumit P; Chongkongkiat P; Khositseth A
Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
[TBL] [Abstract][Full Text] [Related]
8. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.
Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C
J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409
[TBL] [Abstract][Full Text] [Related]
9. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
10. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
[TBL] [Abstract][Full Text] [Related]
11. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
Letshwiti JB; Sirc J; O'Kelly R; Miletin J
Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
[TBL] [Abstract][Full Text] [Related]
13. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.
Khan SS; Sithisarn T; Bada HS; Vranicar M; Westgate PM; Hanna M
J Perinatol; 2017 Dec; 37(12):1319-1324. PubMed ID: 28906496
[TBL] [Abstract][Full Text] [Related]
14. Application of block matching method-based Echocardiography combined with serum NT-PROBNP level detection in the early prediction of PDA in premature infants.
Wang C; Shi Y; Ji J
Pak J Med Sci; 2021; 37(6):1657-1661. PubMed ID: 34712301
[TBL] [Abstract][Full Text] [Related]
15. Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment.
Martinovici D; Vanden Eijnden S; Unger P; Najem B; Gulbis B; Maréchal Y
Pediatr Cardiol; 2011 Oct; 32(7):953-7. PubMed ID: 21656237
[TBL] [Abstract][Full Text] [Related]
16. Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants.
Rodriguez-Blanco S; Oulego-Erroz I; Gautreaux-Minaya S; Perez-Muñuzuri A; Couce-Pico ML
J Perinatol; 2018 Jul; 38(7):881-888. PubMed ID: 29785059
[TBL] [Abstract][Full Text] [Related]
17. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
[TBL] [Abstract][Full Text] [Related]
19. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
König K; Guy KJ; Drew SM; Barfield CP
Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
[TBL] [Abstract][Full Text] [Related]
20. Application of NT-proBNP in ventilator weaning for preterm infants with RDS.
Zhang Q; Shi ZY; Luo CH; Wang L; Zhang SS; Cheng XR; Zhang Q; Xu QY; Guo HX; Cheng XY; Sheng GY
Pediatr Pulmonol; 2014 Aug; 49(8):757-63. PubMed ID: 24019216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
